Global Artificial Kidney Market
Global Artificial Kidney Market

Artificial Kidney Comprehensive Study by Type (Wearable Artificial Kidney, Implantable Artificial Kidney), Application (Adults, Pediatrics) Players and Region - Global Market Outlook to 2024

Artificial Kidney Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2019 Edition 212 Pages 166 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Artificial Kidney Market Overview:
Growing geriatric population, increasing disposable income and rising life expectancy are expected to boost the market of Artificial Kidney Market. Kidney disease is the 9th leading cause of death in the country. According to the National Kidney Foundation around 10% of the population is suffering from chronic kidney diseases globally. Artificial Kidney refers to a device used to filter the blood of the person suffering from kidney damage. It is also known as haemodialyzer. The artificial kidney replicates the work of real kidney and eliminated the need of for dialysis. It helps to produce the hormone, regulate blood pressure, promote red cell and support bone health. It reduces the kidney disease and allows the patient to stay quality life. Some of the key players profiled in the study are Baxter International Inc. (United States), Xcorporeal Inc. (United States), Medtronic, (United States), DaVita Inc. (United States), Merit Medical Systems, Inc. (United States), NIPRO Medical Corporation (United States), NxStage (United States), SynCardia Systems (United States), B. Braun Melsungen AG (Germany) and Fresenius (Germany).

On the basis of geography, the market of Artificial Kidney has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Drivers
  • Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder
  • Rising In the Disposable Income
  • Rise in Number of People Awaiting Organ Transplant

Market Trend
  • Technology Advancement in Field Of Science

Restraints
  • High Cost of Artificial Kidney Hamper Broader Adoption

Opportunities
  • Growing Awareness about Artificial Kidney

Challenges
  • Lack of Surgical Expertise


Major Market Developments:


According to the National Kidney Foundation, " Around 10% of the population are suffering from chronic kidney diseases globally. About two million patients are either under the treatment of dialysis or need a kidney transplant to stay alive." In the global geriatric population, age between 65 to 74, it is predicted that one in five men and one in four women are suffering from chronic kidney diseases. About more than 30 Million American diseases.
FDA approves the clinical testing of a wearable artificial kidney developed by the University of Washington Medical Center. Going forward, wearable artificial kidney systems are expected to be portable, lightweight, user-friendly, smaller, and more convenient.

Target Audience:
Artificial Kidney Manufacturers, Artificial Kidney Distributors/Traders/Wholesalers, Artificial Kidney Subcomponent Manufacturers, Industry Association and Downstream Vendors

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Artificial Kidney market on the basis of product [Wearable Artificial Kidney and Implantable Artificial Kidney] , application [Adults and Pediatrics], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Artificial Kidney market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Artificial Kidney industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Kawasumi Laboratories, Inc. (Japan), Nikkiso Co. Ltd. (Japan) and Asahi Kasei Medical Vo., Ltd. (Japan).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Artificial Kidney market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Wearable Artificial Kidney
  • Implantable Artificial Kidney
By Application
  • Adults
  • Pediatrics
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder
      • 3.2.2. Rising In the Disposable Income
      • 3.2.3. Rise in Number of People Awaiting Organ Transplant
    • 3.3. Market Challenges
      • 3.3.1. Lack of Surgical Expertise
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Field Of Science
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Kidney, by Type, Application and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Artificial Kidney (Value)
      • 5.2.1. Global Artificial Kidney by: Type (Value)
        • 5.2.1.1. Wearable Artificial Kidney
        • 5.2.1.2. Implantable Artificial Kidney
      • 5.2.2. Global Artificial Kidney by: Application (Value)
        • 5.2.2.1. Adults
        • 5.2.2.2. Pediatrics
      • 5.2.3. Global Artificial Kidney Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Artificial Kidney: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Baxter International Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Xcorporeal Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic, (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DaVita Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merit Medical Systems, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NIPRO Medical Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NxStage (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SynCardia Systems (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. B. Braun Melsungen AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Fresenius (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Artificial Kidney Sale, by Type, Application and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Artificial Kidney (Value)
      • 7.2.1. Global Artificial Kidney by: Type (Value)
        • 7.2.1.1. Wearable Artificial Kidney
        • 7.2.1.2. Implantable Artificial Kidney
      • 7.2.2. Global Artificial Kidney by: Application (Value)
        • 7.2.2.1. Adults
        • 7.2.2.2. Pediatrics
      • 7.2.3. Global Artificial Kidney Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Kidney: by Type(USD Million)
  • Table 2. Artificial Kidney Wearable Artificial Kidney , by Region USD Million (2013-2018)
  • Table 3. Artificial Kidney Implantable Artificial Kidney , by Region USD Million (2013-2018)
  • Table 4. Artificial Kidney: by Application(USD Million)
  • Table 5. Artificial Kidney Adults , by Region USD Million (2013-2018)
  • Table 6. Artificial Kidney Pediatrics , by Region USD Million (2013-2018)
  • Table 7. South America Artificial Kidney, by Country USD Million (2013-2018)
  • Table 8. South America Artificial Kidney, by Type USD Million (2013-2018)
  • Table 9. South America Artificial Kidney, by Application USD Million (2013-2018)
  • Table 10. Brazil Artificial Kidney, by Type USD Million (2013-2018)
  • Table 11. Brazil Artificial Kidney, by Application USD Million (2013-2018)
  • Table 12. Argentina Artificial Kidney, by Type USD Million (2013-2018)
  • Table 13. Argentina Artificial Kidney, by Application USD Million (2013-2018)
  • Table 14. Rest of South America Artificial Kidney, by Type USD Million (2013-2018)
  • Table 15. Rest of South America Artificial Kidney, by Application USD Million (2013-2018)
  • Table 16. Asia Pacific Artificial Kidney, by Country USD Million (2013-2018)
  • Table 17. Asia Pacific Artificial Kidney, by Type USD Million (2013-2018)
  • Table 18. Asia Pacific Artificial Kidney, by Application USD Million (2013-2018)
  • Table 19. China Artificial Kidney, by Type USD Million (2013-2018)
  • Table 20. China Artificial Kidney, by Application USD Million (2013-2018)
  • Table 21. Japan Artificial Kidney, by Type USD Million (2013-2018)
  • Table 22. Japan Artificial Kidney, by Application USD Million (2013-2018)
  • Table 23. India Artificial Kidney, by Type USD Million (2013-2018)
  • Table 24. India Artificial Kidney, by Application USD Million (2013-2018)
  • Table 25. South Korea Artificial Kidney, by Type USD Million (2013-2018)
  • Table 26. South Korea Artificial Kidney, by Application USD Million (2013-2018)
  • Table 27. Taiwan Artificial Kidney, by Type USD Million (2013-2018)
  • Table 28. Taiwan Artificial Kidney, by Application USD Million (2013-2018)
  • Table 29. Australia Artificial Kidney, by Type USD Million (2013-2018)
  • Table 30. Australia Artificial Kidney, by Application USD Million (2013-2018)
  • Table 31. Rest of Asia-Pacific Artificial Kidney, by Type USD Million (2013-2018)
  • Table 32. Rest of Asia-Pacific Artificial Kidney, by Application USD Million (2013-2018)
  • Table 33. Europe Artificial Kidney, by Country USD Million (2013-2018)
  • Table 34. Europe Artificial Kidney, by Type USD Million (2013-2018)
  • Table 35. Europe Artificial Kidney, by Application USD Million (2013-2018)
  • Table 36. Germany Artificial Kidney, by Type USD Million (2013-2018)
  • Table 37. Germany Artificial Kidney, by Application USD Million (2013-2018)
  • Table 38. France Artificial Kidney, by Type USD Million (2013-2018)
  • Table 39. France Artificial Kidney, by Application USD Million (2013-2018)
  • Table 40. Italy Artificial Kidney, by Type USD Million (2013-2018)
  • Table 41. Italy Artificial Kidney, by Application USD Million (2013-2018)
  • Table 42. United Kingdom Artificial Kidney, by Type USD Million (2013-2018)
  • Table 43. United Kingdom Artificial Kidney, by Application USD Million (2013-2018)
  • Table 44. Netherlands Artificial Kidney, by Type USD Million (2013-2018)
  • Table 45. Netherlands Artificial Kidney, by Application USD Million (2013-2018)
  • Table 46. Rest of Europe Artificial Kidney, by Type USD Million (2013-2018)
  • Table 47. Rest of Europe Artificial Kidney, by Application USD Million (2013-2018)
  • Table 48. MEA Artificial Kidney, by Country USD Million (2013-2018)
  • Table 49. MEA Artificial Kidney, by Type USD Million (2013-2018)
  • Table 50. MEA Artificial Kidney, by Application USD Million (2013-2018)
  • Table 51. Middle East Artificial Kidney, by Type USD Million (2013-2018)
  • Table 52. Middle East Artificial Kidney, by Application USD Million (2013-2018)
  • Table 53. Africa Artificial Kidney, by Type USD Million (2013-2018)
  • Table 54. Africa Artificial Kidney, by Application USD Million (2013-2018)
  • Table 55. North America Artificial Kidney, by Country USD Million (2013-2018)
  • Table 56. North America Artificial Kidney, by Type USD Million (2013-2018)
  • Table 57. North America Artificial Kidney, by Application USD Million (2013-2018)
  • Table 58. United States Artificial Kidney, by Type USD Million (2013-2018)
  • Table 59. United States Artificial Kidney, by Application USD Million (2013-2018)
  • Table 60. Canada Artificial Kidney, by Type USD Million (2013-2018)
  • Table 61. Canada Artificial Kidney, by Application USD Million (2013-2018)
  • Table 62. Mexico Artificial Kidney, by Type USD Million (2013-2018)
  • Table 63. Mexico Artificial Kidney, by Application USD Million (2013-2018)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Artificial Kidney: by Type(USD Million)
  • Table 75. Artificial Kidney Wearable Artificial Kidney , by Region USD Million (2019-2024)
  • Table 76. Artificial Kidney Implantable Artificial Kidney , by Region USD Million (2019-2024)
  • Table 77. Artificial Kidney: by Application(USD Million)
  • Table 78. Artificial Kidney Adults , by Region USD Million (2019-2024)
  • Table 79. Artificial Kidney Pediatrics , by Region USD Million (2019-2024)
  • Table 80. South America Artificial Kidney, by Country USD Million (2019-2024)
  • Table 81. South America Artificial Kidney, by Type USD Million (2019-2024)
  • Table 82. South America Artificial Kidney, by Application USD Million (2019-2024)
  • Table 83. Brazil Artificial Kidney, by Type USD Million (2019-2024)
  • Table 84. Brazil Artificial Kidney, by Application USD Million (2019-2024)
  • Table 85. Argentina Artificial Kidney, by Type USD Million (2019-2024)
  • Table 86. Argentina Artificial Kidney, by Application USD Million (2019-2024)
  • Table 87. Rest of South America Artificial Kidney, by Type USD Million (2019-2024)
  • Table 88. Rest of South America Artificial Kidney, by Application USD Million (2019-2024)
  • Table 89. Asia Pacific Artificial Kidney, by Country USD Million (2019-2024)
  • Table 90. Asia Pacific Artificial Kidney, by Type USD Million (2019-2024)
  • Table 91. Asia Pacific Artificial Kidney, by Application USD Million (2019-2024)
  • Table 92. China Artificial Kidney, by Type USD Million (2019-2024)
  • Table 93. China Artificial Kidney, by Application USD Million (2019-2024)
  • Table 94. Japan Artificial Kidney, by Type USD Million (2019-2024)
  • Table 95. Japan Artificial Kidney, by Application USD Million (2019-2024)
  • Table 96. India Artificial Kidney, by Type USD Million (2019-2024)
  • Table 97. India Artificial Kidney, by Application USD Million (2019-2024)
  • Table 98. South Korea Artificial Kidney, by Type USD Million (2019-2024)
  • Table 99. South Korea Artificial Kidney, by Application USD Million (2019-2024)
  • Table 100. Taiwan Artificial Kidney, by Type USD Million (2019-2024)
  • Table 101. Taiwan Artificial Kidney, by Application USD Million (2019-2024)
  • Table 102. Australia Artificial Kidney, by Type USD Million (2019-2024)
  • Table 103. Australia Artificial Kidney, by Application USD Million (2019-2024)
  • Table 104. Rest of Asia-Pacific Artificial Kidney, by Type USD Million (2019-2024)
  • Table 105. Rest of Asia-Pacific Artificial Kidney, by Application USD Million (2019-2024)
  • Table 106. Europe Artificial Kidney, by Country USD Million (2019-2024)
  • Table 107. Europe Artificial Kidney, by Type USD Million (2019-2024)
  • Table 108. Europe Artificial Kidney, by Application USD Million (2019-2024)
  • Table 109. Germany Artificial Kidney, by Type USD Million (2019-2024)
  • Table 110. Germany Artificial Kidney, by Application USD Million (2019-2024)
  • Table 111. France Artificial Kidney, by Type USD Million (2019-2024)
  • Table 112. France Artificial Kidney, by Application USD Million (2019-2024)
  • Table 113. Italy Artificial Kidney, by Type USD Million (2019-2024)
  • Table 114. Italy Artificial Kidney, by Application USD Million (2019-2024)
  • Table 115. United Kingdom Artificial Kidney, by Type USD Million (2019-2024)
  • Table 116. United Kingdom Artificial Kidney, by Application USD Million (2019-2024)
  • Table 117. Netherlands Artificial Kidney, by Type USD Million (2019-2024)
  • Table 118. Netherlands Artificial Kidney, by Application USD Million (2019-2024)
  • Table 119. Rest of Europe Artificial Kidney, by Type USD Million (2019-2024)
  • Table 120. Rest of Europe Artificial Kidney, by Application USD Million (2019-2024)
  • Table 121. MEA Artificial Kidney, by Country USD Million (2019-2024)
  • Table 122. MEA Artificial Kidney, by Type USD Million (2019-2024)
  • Table 123. MEA Artificial Kidney, by Application USD Million (2019-2024)
  • Table 124. Middle East Artificial Kidney, by Type USD Million (2019-2024)
  • Table 125. Middle East Artificial Kidney, by Application USD Million (2019-2024)
  • Table 126. Africa Artificial Kidney, by Type USD Million (2019-2024)
  • Table 127. Africa Artificial Kidney, by Application USD Million (2019-2024)
  • Table 128. North America Artificial Kidney, by Country USD Million (2019-2024)
  • Table 129. North America Artificial Kidney, by Type USD Million (2019-2024)
  • Table 130. North America Artificial Kidney, by Application USD Million (2019-2024)
  • Table 131. United States Artificial Kidney, by Type USD Million (2019-2024)
  • Table 132. United States Artificial Kidney, by Application USD Million (2019-2024)
  • Table 133. Canada Artificial Kidney, by Type USD Million (2019-2024)
  • Table 134. Canada Artificial Kidney, by Application USD Million (2019-2024)
  • Table 135. Mexico Artificial Kidney, by Type USD Million (2019-2024)
  • Table 136. Mexico Artificial Kidney, by Application USD Million (2019-2024)
  • Table 137. Research Programs/Design for This Report
  • Table 138. Key Data Information from Secondary Sources
  • Table 139. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Kidney: by Type USD Million (2013-2018)
  • Figure 5. Global Artificial Kidney: by Application USD Million (2013-2018)
  • Figure 6. South America Artificial Kidney Share (%), by Country
  • Figure 7. Asia Pacific Artificial Kidney Share (%), by Country
  • Figure 8. Europe Artificial Kidney Share (%), by Country
  • Figure 9. MEA Artificial Kidney Share (%), by Country
  • Figure 10. North America Artificial Kidney Share (%), by Country
  • Figure 11. Global Artificial Kidney share by Players 2018 (%)
  • Figure 12. Global Artificial Kidney share by Players (Top 3) 2018(%)
  • Figure 13. Global Artificial Kidney share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Baxter International Inc. (United States) Revenue: by Geography 2018
  • Figure 17. Xcorporeal Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Xcorporeal Inc. (United States) Revenue: by Geography 2018
  • Figure 19. Medtronic, (United States) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic, (United States) Revenue: by Geography 2018
  • Figure 21. DaVita Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. DaVita Inc. (United States) Revenue: by Geography 2018
  • Figure 23. Merit Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Merit Medical Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 25. NIPRO Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. NIPRO Medical Corporation (United States) Revenue: by Geography 2018
  • Figure 27. NxStage (United States) Revenue, Net Income and Gross profit
  • Figure 28. NxStage (United States) Revenue: by Geography 2018
  • Figure 29. SynCardia Systems (United States) Revenue, Net Income and Gross profit
  • Figure 30. SynCardia Systems (United States) Revenue: by Geography 2018
  • Figure 31. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. B. Braun Melsungen AG (Germany) Revenue: by Geography 2018
  • Figure 33. Fresenius (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Fresenius (Germany) Revenue: by Geography 2018
  • Figure 35. Global Artificial Kidney: by Type USD Million (2013-2018)
  • Figure 36. Global Artificial Kidney: by Application USD Million (2013-2018)
  • Figure 37. South America Artificial Kidney Share (%), by Country
  • Figure 38. Asia Pacific Artificial Kidney Share (%), by Country
  • Figure 39. Europe Artificial Kidney Share (%), by Country
  • Figure 40. MEA Artificial Kidney Share (%), by Country
  • Figure 41. North America Artificial Kidney Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Baxter International Inc. (United States)
  • Xcorporeal Inc. (United States)
  • Medtronic, (United States)
  • DaVita Inc. (United States)
  • Merit Medical Systems, Inc. (United States)
  • NIPRO Medical Corporation (United States)
  • NxStage (United States)
  • SynCardia Systems (United States)
  • B. Braun Melsungen AG (Germany)
  • Fresenius (Germany)
Additional players considered in the study are as follows:
Kawasumi Laboratories, Inc. (Japan) , Nikkiso Co. Ltd. (Japan) , Asahi Kasei Medical Vo., Ltd. (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation